Global Bioanalytical Testing Services Market to 2031 – Trend Forecast and Growth Opportunities –

DUBLIN–(BUSINESS WIRE)–That “Global Bioanalytical Testing Services Market 2021-2031 by Molecule Type, Application, Test Type, Workflow Process, Therapeutic Area, End-User and Region: Trend Forecast and Growth Opportunity” Report has been added Offer.

The global market for bioanalytical testing services will reach US$7,902.9 million by 2031 and grow at 9.1% annually over the period 2021-2031, driven by increasing demand for analytical testing of biologics and biosimilars amid the COVID-19 pandemic , the increasing preference for outsourcing analytical testing and growing research and development spending in the pharmaceutical and biopharmaceutical industries and the increasing adoption of the Quality by Design (QbD) approach.

This report is based on an exhaustive study of the entire global Bioanalytical Testing Services Market and all its sub-segments through comprehensively detailed classifications. In-depth analysis and reviews are generated from top-notch primary and secondary sources of information, with input from industry experts across the value chain. The report is based on 2018-2021 studies and provides forecasts from 2022 to 2031 with 2021 as the base year.

In-depth qualitative analyzes include the identification and investigation of the following aspects:

  • market structure

  • growth accelerator

  • limitations and challenges

  • New product trends and market opportunities

  • Porter’s Five Powers

The trend and prospect of the global market is forecast from an optimistic, balanced and conservative perspective in consideration of COVID-19. The balanced (most probable) projection is used to quantify the global Bioanalytical Testing Services Market in each aspect of the classification from the perspective of molecule type, application, test type, workflow process, therapeutic area, end user and region.

Selected key players:

  • Charles River Laboratories International Inc.

  • Covance Inc.

  • Eurofins Scientific


  • Intertek Group PLC

  • IQVIA Holdings, Inc.

  • Holdings of Laboratory Corporation of America

  • Medpace Holdings, Inc.

  • Pace Analytical Services LLC.

  • Parexel International Corporation

  • PPD Inc.

  • SGS SA

  • Syneos Health, LLC

  • Toxicon Corporation

  • WuXi Apptech Co.,Ltd.

Main topics covered:

1 Introduction

2 Market overview and dynamics

2.1 Market Size and Forecast

2.1.1 Impact of COVID-19 on the global economy

2.1.2 Impact of COVID-19 on the market

2.2 Key Growth Drivers

2.3 Market Restrictions and Challenges

2.4 New opportunities and market trends

2.5 Porter’s Five Forces Analysis

3 Global Market Segmentation by Molecule Type

3.1 Market Overview by Molecule Type

3.2 Small Molecules

3.3 Large Molecules

3.3.1 LC-MS studies

3.3.2 Immunoassays

3.3.3 Other Large Molecule Tests

4 Global Market Segmentation by Application

4.1 Market Overview by Application

4.2 Bioavailability and Bioequivalence Studies

4.3 Pharmacokinetics (PK)

4.4 Pharmacodynamics (PD)

4.5 Absorption, Distribution, Metabolism, Elimination (ADME)

4.6 Other Applications

5 Global Market Segmentation by Test Type

5.1 Market Overview by Test Type

5.2 Cell Based Assays

5.2.1 Bacterial cell-based assays

5.2.2 Viral cell-based assays

5.3 Virological Tests

5.3.1 In vitro virology tests

5.3.2 Virological in vivo tests

5.3.3 Species-Specific Viral PCR Assays

5.4 Serology, immunogenicity and neutralizing antibodies (SINA)

5.4.1 Bacterial serology, immunogenicity and neutralizing antibodies

5.4.2 Viral serology, immunogenicity and neutralizing antibodies

5.5 Method Development Optimization and Validation (MDOV)

5.6 Biomarker Tests

5.7 Pharmacokinetic tests

5.8 Other Types of Tests

6 Global Market Segmentation by Workflow Process

6.1 Market Overview by Workflow Process

6.2 Sample Preparation

6.2.1 Protein precipitation

6.2.2 Liquid-Liquid Extraction (LLE)

6.2.3 Solid Phase Extraction (SPE)

6.3 Sample Analysis

6.3.1 Hyphen technique

6.3.2 Chromatographic Technique

6.3.3 Electrophoresis

6.3.4 Ligand Binding Assay

6.3.5 Mass Spectrometry

6.3.6 Nuclear Magnetic Resonance

6.4 Other Workflow Processes

7 Global market segmentation by therapeutic areas

7.1 Market Overview by Therapeutic Areas

7.2 Oncology

7.3 Neurology

7.4 Infectious Diseases

7.5 Gastroenterology

7.6 Cardiology

7.7 Other therapeutic areas

8 Global Market Segmentation by End User

8.1 Market Overview by End User

8.2 Pharmaceutical and Biopharmaceutical Companies

8.3 Contract Development and Manufacturing Organizations (CDMOs)

8.4 Contract Research Organizations (CROs)

9 Global Market Segmentation by Regions

10 competitive landscape

10.1 Overview of Key Providers

10.2 New Product Introductions, Partnerships, Investments and Mergers and Acquisitions

10.3 Company Profiles

For more information about this report, see

Leave a Comment